Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
34M
-
Shares change
-
+6.89M
-
Total reported value, excl. options
-
$991M
-
Value change
-
+$213M
-
Put/Call ratio
-
0.33
-
Number of buys
-
97
-
Number of sells
-
-29
-
Price
-
$29.17
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q2 2020
144 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q2 2020.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34M shares
of 69.1M outstanding shares and own 49.17% of the company stock.
Largest 10 shareholders include NORWEST VENTURE PARTNERS XI, LP (2.35M shares), NORWEST VENTURE PARTNERS XII, LP (2.35M shares), VANGUARD GROUP INC (2.06M shares), WELLINGTON MANAGEMENT GROUP LLP (1.86M shares), BlackRock Inc. (1.84M shares), Capital Research Global Investors (1.5M shares), ALLIANCEBERNSTEIN L.P. (1.39M shares), Clearbridge Investments, LLC (1.36M shares), JANUS HENDERSON GROUP PLC (1.24M shares), and Capital International Investors (1.22M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.